Hematological Malignancies: Molecular Mechanisms and Therapy, Second Edition. [PDF]
Int J Mol SciBouziana S.
europepmc +1 more source
Chronotherapy in Hematological Malignancies: Evaluating the Rationale and Evidence. [PDF]
Pharmacol Res PerspectBelančić A +7 more
europepmc +1 more source
The role of notch signaling in tumor angiogenesis in hematological malignancies. [PDF]
Front OncolTamma R, Benagiano V, Ribatti D.
europepmc +1 more source
CAR-NK cell therapy for hematological malignancies. [PDF]
Blood AdvManzar GS +5 more
europepmc +1 more source
CD22 as a Target for Hematological Malignancies and Autoimmune Diseases. [PDF]
Int J Mol SciChen X +7 more
europepmc +1 more source
Mutational signatures in hematological malignancies. [PDF]
Einstein (Sao Paulo)Sartori FA +3 more
europepmc +1 more source
Biology of p53 protein isoforms and their significance in hematological malignancies. [PDF]
Front OncolJanik AM +3 more
europepmc +1 more source
Predictors and outcomes of recurrent bloodstream infection in hematological malignancies: a multicenter real-world study. [PDF]
Front Cell Infect MicrobiolTang Y +8 more
europepmc +1 more source
Protein palmitoylation in hematological malignancies: mechanistic links to lipid metabolic reprogramming and therapy resistance. [PDF]
Front ImmunolZhao Q, Mei J, Qian S, Pu J, Li F.
europepmc +1 more source
Malondialdehyde at the Crossroads of Oxidative Stress, Lipid Peroxidation, Ferroptosis, and Hematological Malignancies: A Narrative Review. [PDF]
BiomedicinesLi Pomi F +6 more
europepmc +1 more source